Showing results (101-110 of 1,019) with videos related to
Sort By:
Pageof 102
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 23, 2021
Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?Chi-Un Pae, Changsu Han, Won-Myong Bahk, et al.Expert Review of Neurotherapeutics|August 1, 2013
Dilemma for enhancing psychiatrists' adherence to guideline (evidence)-based practiceChangsu Han, Sheng-Min Wang, Soo Jung Lee, et al.Expert Review of Neurotherapeutics|August 28, 2015
Five potential therapeutic agents as antidepressants: a brief review and future directionsSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.International Clinical Psychopharmacology|November 6, 2014
Quetiapine augmentation for depression: dosing pattern in routine practiceChi-Un Pae, Sheng-Min Wang, Changsu Han, et al.Depression and Anxiety|November 18, 2006
Aripiprazole augmentation for treatment of patients with inadequate antidepressants responseChi-Un Pae, Ashwin A Patkar, Tae-Youn Jun, et al.The Primary Care Companion for CNS Disorders|December 23, 2015
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive DisorderShilpa Rele, Robert Millet, Sungman Kim, et al.Current Opinion in Investigational Drugs (London, England : 2000)|January 8, 2009
Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopauseChi-Un Pae, Min-Hyeon Park, David M Marks, et al.Psychiatry Investigation|April 14, 2015
Vilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of actionSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 21, 2020
Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation StudyChi-Un Pae, Changsu Han, Won-Myong Bahk, et al.International Clinical Psychopharmacology|October 11, 2013
Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment settingChi-Un Pae, Sheng-Min Wang, Changsu Han, et al.Pageof 102